Second-generation drug-eluting stents and the continuous need for rapidly available real-world data.
Mukherjee
Debabrata
D
Moliterno
David J
DJ
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000191:economics / Q000295:instrumentation* / Q000401:mortality; D003324:Coronary Artery Disease / Q000191:economics / Q000401:mortality / Q000628:therapy*; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D054855:Drug-Eluting Stents / Q000191:economics; D019317:Evidence-Based Medicine; D017048:Health Care Costs; D006801:Humans; D008670:Metals; D009203:Myocardial Infarction / Q000191:economics / Q000209:etiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011474:Prosthesis Design; D011788:Quality of Life; D012042:Registries; D015607:Stents / Q000191:economics; D013997:Time Factors; D016896:Treatment Outcome
D008670:Metals; D010975:Platelet Aggregation Inhibitors